<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01972230</url>
  </required_header>
  <id_info>
    <org_study_id>17713</org_study_id>
    <secondary_id>Claudia</secondary_id>
    <nct_id>NCT01972230</nct_id>
  </id_info>
  <brief_title>Sevoflurane Protective Effect on Ischemia Reperfusion Injury in Microvascular Surgery</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regina Elena Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regina Elena Cancer Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to evaluate the possible protective effect of anesthetic technique balanced
      (BAL) compared to total intravenous anesthetic technique (TIVA-TCI) in ischemia reperfusion
      injury in microvascular flap in plastic surgery. The investigators will evaluate the
      viability of the flap using tissue oximetry monitoring and the level of biochemical markers
      in a circle at the end of the intervention.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>tissutal oximetry average value of the flap measured with INVOS (In Vivo Optical Spectroscopy) system continuously.</measure>
    <time_frame>24 hours from the end of intervention</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">128</enrollment>
  <condition>Microvascular Breast Flap in Plastic Surgery</condition>
  <arm_group>
    <arm_group_label>Bilanced group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sevofluorane adjusted to obtain an Et-Sevo of 1.8-2%, for all the time of the surgical procedure.
Remifentanyl TCI adjusted according to protocol to maintain the range of 1-3 ng / ml.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TCI group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol 3-4 mg / ml and remifentanyl 1-3 ng / ml according to protocol TCI</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <arm_group_label>Bilanced group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diprivan + Remifentanil TCI</intervention_name>
    <arm_group_label>TCI group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 yr

          -  ASA (American Society of Anesthesiology) I-II

        Exclusion Criteria:

          -  Known unusual reaction to anesthetic drugs

          -  Evaluation of anesthesia increased risk for malignant hyperthermia.

          -  History of vascular disease.

          -  History of bleeding diathesis.

          -  Tabagism
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Regina Elena Cancer Institute</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <zip>00144</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2013</study_first_submitted>
  <study_first_submitted_qc>October 29, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2013</study_first_posted>
  <last_update_submitted>April 6, 2016</last_update_submitted>
  <last_update_submitted_qc>April 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Regina Elena Cancer Institute</investigator_affiliation>
    <investigator_full_name>Ester Forastiere</investigator_full_name>
    <investigator_title>director</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

